Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: RE: Thats right.. as I wrote, our IP is collateralizing the debentures.

RE: Thats right.. as I wrote, our IP is collateralizing the debentures.

posted on Mar 17, 2005 10:15AM
``Thats right.. as I wrote, our IP is collateralizing the debentures.``

That goes without question....

My main question was....what happens when the other team starts if able....to leverage the IP ?

If incumbrance is not measured by either side....where does it leave the IP ?

Normal borrowing requires incumbrance to be removed...or methods to balance value.

doni

Share
New Message
Please login to post a reply